Skip to main content

Table 6 Multivariate logistic regression analysis of potential risk factors for T upstaging as a result of mpMRI

From: Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience

  OR 95% confidence interval p-value
Low-risk PSA (<10 ng/ml) 0.37 (0.11, 1.15) 0.096
Intermediate-risk PSA (10–20 ng/ml) 0.29 (0.08, 0.93) 0.043
Low-risk Gleason score (<7) 0.99 (0.27, 3.65) 0.99
Intermediate-risk Gleason score (7) 1.88 (0.51, 7.11) 0.34
Age 1.02 (0.95, 1.10) 0.54
ADT pre-mpMRI 1.34 (0.55, 3.25) 0.52
  1. Multivariate logistic regression analysis was used to demonstrate the relative probability of tumor upstaging after mpMRI of the prostate in patients initially staged as cT1-cT2 (n = 97) depending on specific patient parameters. Patients in the intermediate-risk PSA group had a significantly lower probability of upstaging due to mpMRI than patients in the high-risk PSA group (p = 0.043). OR = Odds ratio. ADT = Androgen deprivation therapy.
\